Form 4: Centene Director Wayne DeVeydt Reports Share Acquisition and Option Holdings Under 10b5-1 Plan

Centene Corp Director Wayne DeVeydt reported the acquisition of 602 shares of common stock and updated his beneficial ownership, including existing stock options, through a pre-planned transaction.

Summary

• Wayne S. DeVeydt, a Director of Centene Corp (CNC), reported changes in his beneficial ownership.
• On June 30, 2025, DeVeydt acquired 602 shares of Centene Common Stock at a price of $0 per share. This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned future transaction.
• Following this transaction, DeVeydt beneficially owns 19,523.274 shares of Common Stock, which includes 3,579 shares of restricted stock units subject to vesting requirements.
• DeVeydt also holds 10,000 Common Stock Options with an exercise price of $80.57, which became exercisable on February 7, 2025, and are set to expire on February 7, 2032.

Sentiment

Score: 7

Explanation: The filing reports a routine acquisition of shares by a director, likely as part of equity compensation, and updates on existing option holdings. This indicates continued alignment of interests between the director and shareholders, without any negative disclosures.

Positives

• Acquisition of 602 shares by a director, indicating continued alignment of interests with shareholders.
• The transaction was executed under a Rule 10b5-1(c) plan, demonstrating pre-planned and compliant insider trading.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, beyond the future transaction date for the share acquisition.

Industry Context

This filing is specific to an individual insider's transaction and does not provide broader industry context or trends. It reflects standard equity compensation practices for corporate directors within the healthcare sector.

Comparison to Industry Standards

• The acquisition of shares at a $0 price is typical for equity compensation such as restricted stock unit (RSU) vesting or performance share grants, which are common practices across industries for aligning executive and director interests with shareholders.
• Holding stock options with a defined exercise price and expiration date is also a standard component of executive and director compensation packages in publicly traded companies, comparable to practices at peers like UnitedHealth Group (UNH) or Elevance Health (ELV) in the healthcare sector.

Related Party Transactions

• The acquisition of shares by a director is inherently a related party transaction (insider transaction) as it involves a key management personnel and the company's securities.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director, particularly through equity compensation, generally aligns the director's interests with shareholders, potentially fostering long-term value creation.

Key Dates

Recommendation

Keywords

Centene Corp, CNC, Wayne DeVeydt, Form 4, SEC filing, insider trading, stock acquisition, stock options, beneficial ownership, director, equity compensation, Rule 10b5-1